Medicinova Inc
XNAS:MNOV 4:00:00 PM EDT
| Market Cap (Intraday) | 63.98M |
| Current PE | N/A |
| Forward PE | N/A |
| 2yr Forward PE | N/A |
| 10-Day MA | $1.36 |
| 50-Day MA | $1.41 |
| 200-Day MA | $1.41 |
Medicinova Inc Stock, XNAS:MNOV
4275 Executive Square, Suite 300, La Jolla, California 92037
United States of America
Phone: +1.858.373.1500
Number of Employees: 13
Description
MediciNova, Inc. is a biopharmaceutical company, which focuses on developing novel therapeutics for the treatment of serious diseases with unmet medical needs and a commercial focus. Its programs include MN-001, MN-166 neurology diseases, and MN-221 respiratory diseases. The company was founded by Yuichi Iwaki on September 26, 2000 and is headquartered in La Jolla, CA.


